首页> 美国卫生研究院文献>PLoS Clinical Trials >Cost-Effectiveness of Genotypic Antiretroviral Resistance Testing in HIV-Infected Patients with Treatment Failure

【2h】

Cost-Effectiveness of Genotypic Antiretroviral Resistance Testing in HIV-Infected Patients with Treatment Failure

机译：基因型抗逆转录病毒耐药性检测在治疗失败的艾滋病毒感染患者中的成本效益

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

BackgroundGenotypic antiretroviral resistance testing (GRT) in HIV infection with drug resistant virus is recommended to optimize antiretroviral therapy, in particular in patients with virological failure. We estimated the clinical effect, cost and cost-effectiveness of using GRT as compared to expert opinion in patients with antiretroviral treatment failure.

机译：背景技术建议对HIV感染抗药性病毒进行基因型抗逆转录病毒耐药性检测（GRT），以优化抗逆转录病毒治疗，特别是对于病毒学衰竭的患者。与专家意见相比，我们估计了抗逆转录病毒治疗失败的患者使用GRT的临床效果，成本和成本效益。

著录项

期刊名称 PLoS Clinical Trials
作者
Pedram Sendi; Huldrych F. Günthard; Mathew Simcock; Bruno Ledergerber; Jörg Schüpbach; Manuel Battegay;
展开▼
作者单位

展开▼
年(卷),期 2007(2),1
年度 2007
页码 e173
总页数 8
原文格式 PDF
正文语种
中图分类
关键词

相似文献

外文文献
中文文献
专利

1. Cost effectiveness analysis of routine use of genotypic antiretroviral resistance testing after failure of antiretroviral treatment for HIV. [J] . Corzillius M, Muhlberger N, Sroczynski G, Antiviral therapy . 2004,第1期

机译：HIV抗逆转录病毒治疗失败后常规使用基因型抗逆转录病毒耐药性测试的成本效益分析。
2. Characterization of Genotypic Mutations and Antiretroviral Resistance among Viremic HIV-Infected Patients in a High HIV Prevalence Area: Treatment Challenge and Transmission Risk [J] . AliAsad Arastu, Virginia Kan World Journal of AIDS . 2011,第3期

机译：高艾滋病毒流行地区的病毒性艾滋病毒感染患者中基因型突变和抗逆转录病毒耐药性的表征：治疗挑战和传播风险
3. Utility of repeat genotypic resistance testing and clinical response in patients with three class resistance and virologic treatment failure. [J] . Badri SM, Adeyemi OM, Max BE, AIDS patient care and STDs . 2007,第8期

机译：在三级耐药和病毒治疗失败的患者中进行重复基因型耐药性测试和临床反应的实用性。
4. Effect of highly active antiretroviral therapy (HAART) on lipid abnormalities in HIV-infected patients [C] . Estari Mamidala 2011 international conference on medical information and bioengineering. . 2011

机译：高效抗逆转录病毒疗法（HAART）对HIV感染患者血脂异常的影响
5. Cost effectiveness analysis of abacavir/lamivudine versus tenofovir/emtricitabine combination therapy as part of highly active antiretroviral therapy in treatment naive HIV-infected patients. [D] . Giguere, Pierre. 2010

机译：阿巴卡韦/拉米夫定与替诺福韦/恩曲他滨联合疗法作为高活性抗逆转录病毒疗法治疗未受HIV感染的患者的成本效益分析。
6. Is There a Need for Viral Load Testing to Assess Treatment Failure in HIV-Infected Patients Who Are about to Change to Tenofovir-Based First-Line Antiretroviral Therapy? Programmatic Findings from Myanmar [O] . Nay Thiha, Palanivel Chinnakali, Anthony D. Harries, 2011

机译：是否需要进行病毒载量测试以评估即将转用基于Tenofovir的一线抗逆转录病毒疗法的HIV感染患者的治疗失败？来自缅甸的程序化发现
7. Cost-Effectiveness of Genotypic Antiretroviral Resistance Testing in HIV-Infected Patients with Treatment Failure [O] . Sendi, Pedram, Günthard, Huldrych F., Simcock, Mathew, 2007

机译：基因型抗逆转录病毒耐药性检测在治疗失败的艾滋病毒感染患者中的成本效益

Cost-Effectiveness of Genotypic Antiretroviral Resistance Testing in HIV-Infected Patients with Treatment Failure

摘要

著录项

相似文献

相关主题

期刊订阅